Sodium fructose diphosphate
Indication
It is suitable for improving angina pectoris, acute myocardial infarction and arrhythmia caused by coronary heart disease, and myocardial ischemia caused by heart failure.
Packaging Specification
API (for injection)
Manufacturer
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
-
Founded in:
1993-08-11 -
Address:
No. 978 Chuansha Road, Pudong New Area, Shanghai -
Tax NO.:
91310115133738906M -
Registered Funds:
1,052,429,132 yuan -
Website:
-
Email: